Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Types of RNA01:20

Types of RNA

13.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
13.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

934
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
934
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

811
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
811

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A novel chimeric peptide binds MC3T3‑E1 cells to titanium and enhances their proliferation and differentiation.

Molecular medicine reports·2013
Same author

Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2013
Same author

Biological activities and corresponding SARs of andrographolide and its derivatives.

Mini reviews in medicinal chemistry·2013
Same author

The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis.

Familial cancer·2013
Same author

Understanding the structure and mechanism of formation of a new magnetic microbubble formulation.

Theranostics·2013
Same author

Analysis of IL-17 gene polymorphisms in Chinese patients with dilated cardiomyopathy.

Human immunology·2013

関連する実験動画

Updated: Apr 25, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

7.5K

長い非コーディングRNAは,心臓を病理的な高縮から保護する.

Pei Han1,2, Wei Li1, Chiou-Hong Lin1

  • 1Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305.

Nature
|August 15, 2014
PubMed
まとめ

新たに発見された心臓特異の長いノンコーディングRNAであるMhrtは,染色体リモデレータBrg1.1を阻害することによって,成人心臓を保護する. Mhrtの喪失は,心不全の発達に不可欠ですが,それを回復することは,心機能不全を予防します.

さらに関連する動画

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

19.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

関連する実験動画

Last Updated: Apr 25, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

7.5K
Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

19.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

科学分野:

  • 分子生物学は分子生物学である.
  • 遺伝学 遺伝学とは
  • 心臓病学 心臓病学

背景:

  • 大人の心臓機能におけるロング・ノンコーディングRNA (lncRNA) の役割と,それらの核細胞再構成の調節は,ほとんど不明のままである.
  • 反意味転写が一般的であり,ミオシン重鎖7 (Myh7) は心臓収縮に不可欠なタンパク質をコードする重要な遺伝子である.

研究 の 目的:

  • 大人の心臓における新しいlncRNAを特定し,特徴づけること.
  • lncRNAが染色体改造複合体と相互作用するメカニズムを解明する.
  • これらのlncRNAsが心不全および心筋病の発生における役割を調査する.

主な方法:

  • Mhrt.と命名されたマウスのMyh7ロシからの心臓特異のlncRNAトランスクリプトの識別と特徴付け.
  • 病理学的ストレス下におけるMhrtとBrg1-Hdac-Parpクロマチン抑制複合体との相互作用の調査.
  • ゲノムDNA標的へのBrg1結合を防止するMhrtの役割とそのクロマチンの改造への影響の分析.

主要な成果:

  • Mhrtは心臓特異性があり,成人心臓に豊富に存在するlncRNAであり,Brg1-Hdac-Parp複合体経由で病理的なストレスによって抑制されます.
  • Mhrtの抑制は,心筋病の発症に不可欠であり,Mhrtのレベルを回復することは,心筋縮および心不全から保護します.
  • Mhrtは,Brg1のヘリカーゼドメインに直接結合し,DNA結合活動を競争的に抑制し,異常遺伝子発現と心筋症候群を予防します.

結論:

  • Mhrt と Brg1 を含む新しい lncRNA-クロマチンメカニズムは,心臓の機能を維持するために不可欠です.
  • MHRTは,ストレス誘発のクロマチンの改造を阻害することによって,心臓保護因子として作用します.
  • この研究は,lncRNA-クロマチンの相互作用のための新しいパラダイムを確立し,ヒト心筋疾患における保存されたメカニズムを特定します.